LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 12.17 | 27.76 | 36 | 489 | 0.0736 | 0.0648 | MN20160318_Q01 | L08 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 12.17 | 27.76 | 1143 | 489 | 2.3371 | 1.4553 | MN20160318_Q01 | L08 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 13.87 | 27.76 | 97 | 604 | 0.1604 | 0.3251 | MN20160318_Q01 | G09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 13.87 | 27.76 | 903 | 604 | 1.4933 | 1.1888 | MN20160318_Q01 | G09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 13.87 | 27.76 | 4 | 604 | 0.0066 | -0.3533 | MN20160318_Q01 | H12 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 13.87 | 27.76 | 969 | 604 | 1.6024 | 1.2238 | MN20160318_Q01 | H12 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 13.87 | 27.76 | 391 | 604 | 0.6466 | 0.8131 | MN20160318_Q01 | L08 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 13.87 | 27.76 | 1182 | 604 | 1.9546 | 1.3255 | MN20160318_Q01 | L08 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 15.58 | 27.76 | 402 | 685 | 0.5864 | 0.7821 | MN20160318_Q01 | G09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 15.58 | 27.76 | 946 | 685 | 1.3799 | 1.1442 | MN20160318_Q01 | G09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 15.58 | 27.76 | 6 | 685 | 0.0088 | -0.2819 | MN20160318_Q01 | H12 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 15.58 | 27.76 | 988 | 685 | 1.4411 | 1.1644 | MN20160318_Q01 | H12 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 15.58 | 27.76 | 612 | 685 | 0.8927 | 0.9515 | MN20160318_Q01 | L08 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 15.58 | 27.76 | 1243 | 685 | 1.8131 | 1.2745 | MN20160318_Q01 | L08 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 17.28 | 27.76 | 800 | 838 | 0.9538 | 0.9809 | MN20160318_Q01 | G09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 17.28 | 27.76 | 956 | 838 | 1.1398 | 1.0540 | MN20160318_Q01 | G09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 17.28 | 27.76 | 12 | 838 | 0.0143 | -0.1568 | MN20160318_Q01 | H12 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 17.28 | 27.76 | 1011 | 838 | 1.2054 | 1.0775 | MN20160318_Q01 | H12 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 17.28 | 27.76 | 977 | 838 | 1.1649 | 1.0630 | MN20160318_Q01 | L08 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 17.28 | 27.76 | 1268 | 838 | 1.5118 | 1.1754 | MN20160318_Q01 | L08 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 18.98 | 27.76 | 875 | 941 | 0.9297 | 0.9715 | MN20160318_Q01 | G09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 18.98 | 27.76 | 981 | 941 | 1.0423 | 1.0164 | MN20160318_Q01 | G09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 18.98 | 27.76 | 21 | 941 | 0.0223 | -0.0534 | MN20160318_Q01 | H12 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 18.98 | 27.76 | 1038 | 941 | 1.1029 | 1.0389 | MN20160318_Q01 | H12 |
MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 18.98 | 27.76 | 1102 | 941 | 1.1709 | 1.0631 | MN20160318_Q01 | L08 |